![Michael Elliott](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Michael Elliott's former jobs include Vice President-Immunology Scientific Innovation at Johnson & Johnson and Chief Scientific Officer at Immunovant, Inc. He obtained his undergraduate and doctorate degrees from the University of Adelaide.
| Companies | Position | End |
|---|---|---|
| JOHNSON & JOHNSON | Corporate Officer/Principal | - |
| IMMUNOVANT, INC. | Chief Tech/Sci/R&D Officer | - |
Active
Inactive
Listed companies
Private companies
| Private companies | 3 |
|---|---|
Johnson & Johnson
 Johnson & Johnson Pharmaceuticals: MajorHealth Technology Operates as an investment holding company with interests in health care products | Health Technology |
University of Adelaide
 University of Adelaide Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Immunovant, Inc.
 Immunovant, Inc. BiotechnologyHealth Technology Develops restorative therapies for autoimmune diseases | Health Technology |
Select your edition
All financial news and data tailored to specific country editions
